0001801385-24-000009.txt : 20240301
0001801385-24-000009.hdr.sgml : 20240301
20240301201638
ACCESSION NUMBER: 0001801385-24-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240228
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROMANO KATHRYN
CENTRAL INDEX KEY: 0001801385
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 24712508
MAIL ADDRESS:
STREET 1: C/O KRYSTAL BIOTECH, INC.
STREET 2: 2100 WHARTON STREET, SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
FORMER NAME:
FORMER CONFORMED NAME: Romano Kathryn
DATE OF NAME CHANGE: 20200128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821080209
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
4
1
wk-form4_1709342189.xml
FORM 4
X0508
4
2024-02-28
0
0001711279
Krystal Biotech, Inc.
KRYS
0001801385
ROMANO KATHRYN
C/O KRYSTAL BIOTECH, INC.
2100 WHARTON STREET, SUITE 701
PITTSBURGH
PA
15203
0
1
0
0
Chief Accounting Officer
1
Common Stock
2024-02-28
4
M
0
523
63.55
A
13459
D
Common Stock
2024-02-28
4
S
0
523
163.134
D
12936
D
Common Stock
2024-02-28
4
M
0
744
63.55
A
13680
D
Common Stock
2024-02-28
4
S
0
744
164.6031
D
12936
D
Common Stock
2024-02-28
4
M
0
130
63.55
A
13066
D
Common Stock
2024-02-28
4
S
0
130
165.2197
D
12936
D
Common Stock
2024-02-28
4
M
0
100
63.55
A
13036
D
Common Stock
2024-02-28
4
S
0
100
166.215
D
12936
D
Common Stock
2024-02-28
4
M
0
700
63.55
A
13636
D
Common Stock
2024-02-28
4
S
0
700
168.9136
D
12936
D
Common Stock
2024-02-28
4
M
0
203
63.55
A
13139
D
Common Stock
2024-02-28
4
S
0
203
169.468
D
12936
D
Common Stock
2024-02-28
4
M
0
100
63.55
A
13036
D
Common Stock
2024-02-28
4
S
0
100
171.45
D
12936
D
Common Stock
2024-02-28
4
M
0
637
63.55
A
13573
D
Common Stock
2024-02-28
4
S
0
637
162.7254
D
12936
D
Common Stock
2024-02-28
4
M
0
786
63.55
A
13722
D
Common Stock
2024-02-28
4
S
0
786
163.4937
D
12936
D
Common Stock
2024-02-28
4
M
0
1600
63.55
A
14536
D
Common Stock
2024-02-28
4
S
0
1600
164.8444
D
12936
D
Common Stock
2024-02-28
4
M
0
200
63.55
A
13136
D
Common Stock
2024-02-28
4
S
0
200
166.04
D
12936
D
Common Stock
2024-02-28
4
M
0
300
63.55
A
13236
D
Common Stock
2024-02-28
4
S
0
300
167.85
D
12936
D
Common Stock
2024-02-28
4
M
0
1133
63.55
A
14069
D
Common Stock
2024-02-28
4
S
0
1133
169.095
D
12936
D
Common Stock
2024-02-28
4
M
0
210
63.55
A
13146
D
Common Stock
2024-02-28
4
S
0
210
169.751
D
12936
D
Common Stock
2024-02-28
4
M
0
134
63.55
A
13070
D
Common Stock
2024-02-28
4
S
0
134
171.6554
D
12936
D
Stock Option (Right to Buy)
63.55
2024-02-28
2024-02-28
4
M
0
2500
0
D
2032-02-28
Common Stock
2500
35000
D
Stock Option (Right to Buy)
63.55
2024-02-28
2024-02-28
4
M
0
5000
0
D
2032-02-28
Common Stock
5000
30000
D
The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 2,500 shares with a limit price of $140.00 per share.
The transaction was executed in multiple trades ranging from $162.825 to $163.820. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide
upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $164.030 to $164.960. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $165.050 to $165.270. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $168.275 to $169.190. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $169.345 to $170.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 5,000 shares with a limit price of $145.00 per share.
The transaction was executed in multiple trades ranging from $162.115 to $163.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $163.120 to $164.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $164.360 to $165.270. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $165.980 to $166.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $167.540 to $168.010. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $168.680 to $169.500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $169.690 to $169.970. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $171.460 to $172.230. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
50,000 options were granted that vest in four equal annual installments with the first installment vesting on February 28, 2023.
/s/ Kathryn Romano
2024-03-01